Page last updated: 2024-10-26

dipyridamole and Hepatitis B

dipyridamole has been researched along with Hepatitis B in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Hepatitis B: INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shimizu, T1
Horiuchi, T1
Kamitsuji, H1
Murakami, T1
Tamai, H1
De Vita, C1

Other Studies

2 other studies available for dipyridamole and Hepatitis B

ArticleYear
Horizontal transmission of hepatitis B from a father to two brothers.
    European journal of pediatrics, 2003, Volume: 162, Issue:11

    Topics: Adult; Carrier State; Child, Preschool; Dipyridamole; Disease Transmission, Infectious; Drug Therapy

2003
[Problems of the operated patient and suggestions for their treatment].
    Giornale italiano di cardiologia, 1982, Volume: 12, Issue:3

    Topics: Angina Pectoris; Anti-Arrhythmia Agents; Anticoagulants; Anxiety Disorders; Arrhythmias, Cardiac; As

1982